DNA topoisomerase-targeting antitumor agents and drug resistance.

Drug resistance and antiviral agents.

Phytol derivatives as drug resistance reversal agents.

Antineoplastic drug resistance and DNA repair.

Hydantoins as antitumor agents.

Pyridones as potential antitumor agents.

Potential antitumor agents. 64. Synthesis and antitumor evaluation of dibenzo[1,4]dioxin-1-carboxamides: a new class of weakly binding DNA-intercalating agents.

Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents-A drug repurposing strategy.

Microtubule-depolymerizing agents used in antibody-drug conjugates induce antitumor immunity by stimulation of dendritic cells.

Structure-activity studies of antitumor agents based on pyrrolo[1,2-a]benzimidazoles: new reductive alkylating DNA cleaving agents.

Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myeloma.

Potential antitumor agents. 18. Bisquaternary ammonium heterocycles.

Sesquiterpene antitumor agents: inhibitors of cellular metabolism.

Novel Molecular Multilevel Targeted Antitumor Agents.

Potential CNS antitumor agents VI: aziridinylbenzoquinones III.

Potential antitumor agents. 21. Dialkanolamine dialkanesulfonic esters.

Endocrine pharmacology of antiestrogens as antitumor agents.

Molecular structure of antitumor drug steffimycin and modelling of its binding to DNA.

Locating the binding sites of antitumor drug tamoxifen and its metabolites with DNA.

PARP1 Inhibitors: antitumor drug design.

Hexadecylphosphocholine: a new and selective antitumor drug.

Antitumor agents XXIII: Helenalin, and antitumor principle from Anaphalis morrisonicola HAY.

Potential antitumor agents: procarbazine analogs and other methylhydrazine derivatives.

Hybrids of phenylsulfonylfuroxan and coumarin as potent antitumor agents.

Betulinic Acid and its Derivatives as Potential Antitumor Agents.

Suggest Documents

Drug resistance and antiviral agents.

Phytol derivatives as drug resistance reversal agents.

Antineoplastic drug resistance and DNA repair.

Hydantoins as antitumor agents.

Pyridones as potential antitumor agents.

Potential antitumor agents. 64. Synthesis and antitumor evaluation of dibenzo[1,4]dioxin-1-carboxamides: a new class of weakly binding DNA-intercalating agents.

Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents-A drug repurposing strategy.

Microtubule-depolymerizing agents used in antibody-drug conjugates induce antitumor immunity by stimulation of dendritic cells.

Structure-activity studies of antitumor agents based on pyrrolo[1,2-a]benzimidazoles: new reductive alkylating DNA cleaving agents.

Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myeloma.

Potential antitumor agents. 18. Bisquaternary ammonium heterocycles.

Sesquiterpene antitumor agents: inhibitors of cellular metabolism.

Novel Molecular Multilevel Targeted Antitumor Agents.

Potential CNS antitumor agents VI: aziridinylbenzoquinones III.

Potential antitumor agents. 21. Dialkanolamine dialkanesulfonic esters.

Endocrine pharmacology of antiestrogens as antitumor agents.

Molecular structure of antitumor drug steffimycin and modelling of its binding to DNA.

Locating the binding sites of antitumor drug tamoxifen and its metabolites with DNA.

PARP1 Inhibitors: antitumor drug design.

Hexadecylphosphocholine: a new and selective antitumor drug.

Antitumor agents XXIII: Helenalin, and antitumor principle from Anaphalis morrisonicola HAY.

Potential antitumor agents: procarbazine analogs and other methylhydrazine derivatives.

Hybrids of phenylsulfonylfuroxan and coumarin as potent antitumor agents.

Betulinic Acid and its Derivatives as Potential Antitumor Agents.

DNA topoisomerase-targeting antitumor agents and drug resistance.

Recommend Documents

Follow Us